Navigation Links
UCSF Chancellor inducted into Academy of Arts and Sciences
Date:10/9/2010

UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, will be inducted today into the American Academy of Arts and Sciences, alongside some of the world's other most distinguished scholars, artists and institutional leaders.

Desmond-Hellmann, a renowned oncologist and biotechnology leader who now heads the nation's largest public biomedical research institution, was among five members of the 210 new fellows to address her colleagues, focusing on today's unprecedented opportunities to understand human biology and improve human health.

"I want to challenge us to set the bar high, to imagine what's possible, and then to make it happen," she said. "Patients are waiting. These patients and their families deserve our sense of urgency around using all of our scientific knowledge to allow each human being the best chance possible to live a full life without pain and suffering."

Desmond-Hellmann, who took the helm of UCSF in August 2009, has committed her career to expediting the translation of scientific research into life-saving therapies for patients. Trained at UCSF, Desmond-Hellmann spent several years in the early 1990s working as a community oncologist, where she became frustrated with the limited options available to cancer patients.

She went on to lead product development at Genentech Inc., the world's first biotechnology company, which became the nation's top producer of anti-cancer drug treatments during her tenure. As Genentech's president of product development, Desmond-Hellmann oversaw the launch of the cancer drugs Avastin, Herceptin and Rituxan, among others.

Desmond-Hellmann was named to the Biotech Hall of Fame in 2006, has appeared among Fortune's "Top 50 Most Powerful Women in Business," and was named by Forbes as one of the world's seven most powerful innovators and "a hero to legions of cancer patients."

In her role as UCSF chancellor, Desmond-Hellmann oversees a $3.3 billion organization that inclu
'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California -- San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. U of Us Janice Morse inducted into International Nurse Researcher Hall of Fame
2. Director of top 10 nurse midwifery program inducted into the American College of Nurse Midwives
3. Chicago Trial Attorney Inducted as Loyola University Chicago School of Law's First Cooney & Conway Chair in Advocacy
4. Christine P. Carrington, President of NurseTesting Creative Solutions, Inducted into Cambridge Who's Who
5. O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president
6. St. Michaels doctor wins $50,000 N.Y. Academy of Medicine Glaucoma Prize
7. Fired Wal-Mart Employee Accepts Full Scholarship to The Medical Marijuana Academy
8. AcademyHealth honors leading health services researchers
9. The Dawson Academy Announces the Signing of a Joint Marketing Agreement with Ads Next™
10. Brain Academy's Revolutionary New Approach to Tutoring and Test Prep Helps Students Find Academic Success
11. New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... , , , , ... (Nasdaq: WCRX ) today announced its results for the ... 30, 2009 increased 7.1% to $250.8 million over the prior year ... net sales of DORYX, LOESTRIN 24 FE and ESTRACE Cream which ...
... - Quarter Marked by Launch of RYZOLT(TM) in U.S. -, ... Novel Trazodone, ... , , LAVAL, QC, Aug. 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... figures are in Canadian dollars unless otherwise stated. , "The second quarter of 2009 was highlighted ...
... ... and technology solutions, today announced the opening of a Chicago field office to better support ... ... Marathon Health, a leading provider of onsite employee health services and technology solutions, ...
... ... vice president for consulting. , ... St. Louis, MO (Vocus) -- Navvis & Company announces the appointment ... the firm and its clients extensive experience and expertise in health system operations, strategic ...
... expensive patients need fewer health care resources and cost insurers ... care team that tracks their health and offers regular support, ... Bloomberg School of Public Health. The research, published in the ... the first eight months of a randomized controlled trial, patients ...
... , WASHINGTON, Aug. 6 Lung Cancer Alliance ... another $11.8 million of the $20 million lung cancer research ... Research Program (CDMRP). , , (Logo: ... The solicitation invited researchers to compete for $10.5 ...
Cached Medicine News:Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 18Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 2Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 3Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 4Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 5Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 6Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 7Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 8Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 9Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 10Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 11Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 12Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 13Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 14Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 15Health News:Marathon Health Expands Midwest Presence 2Health News:Cleveland Joins Navvis & Company 2Health News:Guided care reduces cost of health care for older persons with chronic conditions 2Health News:LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 2
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: ... waived the Office of Fair Trading (OFT) approval condition to ... of ViroPharma Incorporated (NASDAQ: VPHM).   As a ... on OFT approval, and Shire expects to complete the tender ... time, subject to the satisfaction of all of the remaining ...
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly ... announced that on January 7, 2014, the Company,s board ... Ben-Zion Weiner as its new member of ... Weiner held executive positions with Teva Pharmaceutical Industries Ltd ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented ... C. difficile and TB in ambulances and other transport vehicles, ... is now being used by rescue personnel for the first ... and transport patients from coming in contact with these deadly ... is the first in the nation to begin sanitizing the ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ... Insulin-PH20 (recombinant human insulin with rHuPH20) produced glycemic ... (mealtime) insulin analog. The overall safety and adverse ... and both treatments were well tolerated. Insulin-PH20 achieved ...
... HistoRx, Inc. (privately held), a diagnostics company, announced ... of clinical diagnostic assays based on AQUA® technology. ... specialized laboratory service provider, is launching NexCourse®(1) BCa ... assays based on quantitative immunohistochemistry.  NexCourse BCa by ...
Cached Medicine Technology:Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 2Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 3Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 4Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 5HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 2HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 3
... System supports approaches to Admitting/Discharge/Transfer ... record keeping functions using a ... facilities and cut across institutional ... community clinics, physician, agency, nursing ...
... Dairylands Clinical Information Management ... suite of integrated applications ... departments and automate administrative ... The applications allow organizations ...
... include a Patient Face Sheet, ... many as six custom tabs, ... information is important for you ... Import Manager utility lets you ...
... WEBeDoctor® Physician-office® is an ... physicians, (Solo practice, group ... to complete their normal ... It is a front ...
Medicine Products: